New: NCI-funded clinical trial search
Mednet Logo

When treating younger men with anal cancer do you consider dose to the prostate?

Given risk of secondary malignancies do you make an effort to avoid/spare the prostate or give any specific dose constraints when treating young men with anal or rectal cancers?
1 Answer
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · University of Washington
Answered on · Updated on

Given the proximity of the prostate to a typical anorectal target volume, it would be difficult to completely spare the prostate without increasing the risk of a marginal miss. I would not recommend compromising target coverage to spare the prostate

Clinical concerns about prostate dose could involve...

Join for free or sign in to see the full answer